Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

A letter from the executive editor: A seminal moment for science journalism

Dear Readers, If you’re reading this, you have likely received letters from me before, highlighting STAT’s coverage of health and medicine and appealing to you

November 7, 2024

Investors OrbiMed and Foresite say they’re looking at taking Kinnate private, following pipeline and staff cuts

Kinnate Biopharma’s stock $KNTE soared 59% on Wednesday afternoon after the California drug developer disclosed that two large shareholders have expressed interest in a take-private

November 16, 2023

Rare Syndrome After COVID Vaccines Described

People who experienced rare long-term adverse events after COVID-19 vaccination often had neurologic symptoms, survey data showed. Among 241 people who self-reported a post-vaccination syndrome

December 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.